OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
246
Results
Show all
Save search
Copy query
Show results for
Unknown
(213)
Metabolomics
(17)
Genomics
(7)
Transcriptomics
(5)
Proteomics
(3)
Clinical
(1)
Organisms
Homo sapiens
(4)
Archaea
(3)
Bacteria
(3)
Betaherpesvirinae
(3)
Borrelia
(3)
Botrytis cinerea
(3)
Candida albicans
(3)
Clostridium perfringens
(3)
Cnidaria
(3)
Eukaryota
(3)
Fungi
(3)
Hepatitis B virus
(3)
Human betaherpesvirus 5
(3)
Influenza C virus
(3)
Japanese encephalitis virus group
(3)
Miscanthus x giganteus
(3)
Mycobacterium tuberculosis
(3)
Orthoflavivirus
(3)
Panicum virgatum
(3)
Platyhelminthes
(3)
Rattus
(3)
Saccharomyces cerevisiae
(3)
Salmonella enterica subsp. enterica
(3)
Schizosaccharomyces
(3)
Schizosaccharomyces pombe
(3)
Severe acute respiratory syndrome coronavirus 2
(3)
Staphylococcus aureus
(3)
Streptococcus pneumoniae
(3)
Toxoplasma gondii
(3)
Toxoplasma gondii
(1)
Organisms
Homo sapiens
(3)
Saccharomyces cerevisiae
(1)
Toxoplasma gondii
(1)
Repository
MetaboLights
(16)
ENA
(7)
geo
(4)
pride
(3)
biostudies-arrayexpress
(1)
MetabolomicsWorkbench
(1)
Tissue
Uterus
(1)
Epithelial cell
(1)
Disease
Colorectal Neoplasms
(1)
Colon cancer
(1)
Technology Type
Mass spectrometry
(10)
Mass spectrometry assay
(6)
Mass Spectrometry
(4)
ESI
(1)
Affinity purification coupled with mass spectrometry proteomics
(1)
Bottom-up proteomics
(1)
Shotgun proteomics
(1)
Instrument Platform
Liquid Chromatography MS - negative - reverse phase
(8)
Liquid Chromatography MS - positive - reverse phase
(8)
Liquid Chromatography MS - negative - hilic
(3)
Liquid Chromatography MS - positive - hilic
(3)
Liquid Chromatography MS - negative - reversed-phase-chromatography
(2)
Liquid Chromatography MS - alternating - hilic
(2)
NextSeq 500
(1)
Flow injection analysis MS -
(1)
Liquid Chromatography MS - positive - reversed-phase-chromatography
(1)
Liquid Chromatography MS - alternating - reverse-phase
(1)
Liquid Chromatography MS - negative - reverse-phase
(1)
Publication Date
2025
(10)
2026
(5)
2021
(3)
2024
(3)
2023
(2)
2020
(1)
CHEBI ID
CHEBI:94807
(3)
CHEBI:172638
(3)
CHEBI:9449
(3)
CHEBI:18051
(3)
CHEBI:47823
(3)
CHEBI:16562
(3)
CHEBI:28813
(3)
CHEBI:34735
(3)
CHEBI:80837
(3)
CHEBI:172408
(3)
CHEBI:28283
(3)
CHEBI:65004
(3)
CHEBI:88427
(3)
CHEBI:32368
(3)
CHEBI:17460
(3)
CHEBI:5013
(3)
CHEBI:5301
(3)
CHEBI:16796
(3)
CHEBI:28806
(3)
CHEBI:45919
(3)
CHEBI:28052
(3)
CHEBI:9611
(3)
CHEBI:74767
(3)
CHEBI:16697
(3)
CHEBI:83051
(3)
CHEBI:16422
(3)
CHEBI:6909
(3)
CHEBI:68567
(3)
CHEBI:25351
(3)
CHEBI:24823
(3)
Metabolite Name
Nitazoxanide
(16)
Hexadecanedioic acid
(13)
Pantothenic acid
(11)
Uracil
(10)
Eicosapentaenoic acid
(10)
Citric acid
(10)
Tetradecanedioic acid
(10)
Suberic acid
(10)
L-Tryptophan
(10)
Azelaic acid
(10)
3-Hydroxydodecanoic acid
(10)
Pravastatin
(9)
Indoleacetaldehyde
(9)
Taurocholic acid
(9)
Undecanedioic acid
(9)
Sebacic acid
(9)
Traumatic acid
(9)
Dodecanoic acid
(9)
Erythritol
(9)
Canrenone
(9)
Uridine
(9)
Inosine
(9)
Cholesterol sulfate
(8)
Petroselinic acid
(8)
Octadecanedioic acid
(8)
Heptadecanoic acid
(8)
7-Ketodeoxycholic acid
(8)
Phenylacetic acid
(8)
Pentamidine
(8)
1,11-Undecanedicarboxylic acid
(8)
First Public Date
2021
(2)
2025
(1)
2024
(1)
2023
(1)
2022
(1)
2019
(1)
Classification
protozoa
(1)
Study status
Recruiting
(1)
Study type
Human - High-throughput sequencing
(1)
Interventional
(1)
Release Date
2022
(35)
2021
(33)
2023
(22)
2020
(18)
2024
(17)
2018
(15)
2025
(14)
2019
(14)
2016
(9)
2017
(8)
2014
(7)
2015
(6)
2013
(6)
2012
(4)
2011
(2)
2010
(2)
2007
(1)
2002
(1)
Lab affiliation
Department of Medical Sciences, Clinical Chemistry, Uppsala University, Sweden
(1)
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Republic of Korea
(1)
State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China
(1)
Location
Egypt
(1)
Tags
xref:PubMed:41193440
(1)
xref:PubMed:33957094
(1)
xref:PubMed:36810084
(1)
xref:PubMed:39793570
(1)
pathogen:protozoan
(1)
pathogen
(1)
Keyword
Nitazoxanide
(1)
Previous
page
1 / 25
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
25
Next
page
Sort
by:
Relevance
Page size
10
Nitazoxanide in Patients With Metastatic Colorectal Cancer
The aim of this study is to evaluate the potential efficacy and safety of nitazoxanide in patients with metastatic colorectal cancer.
92929
|
ecrin-mdr-crc
Cite
Saccharomyces cerevisiae
Saccharomyces cerevisiae Raw sequence reads Nitazoxanide
PRJNA487968
|
ENA
Cite
Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer
Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer
PRJNA718525
|
ENA
Cite
Treatment of RSV infection with ribavirin, nitazoxanide and favipiravir
PRJNA846693
|
ENA
Cite
Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis.
Not available
S-EPMC3215101
|
biostudies-literature
Cite
Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells.
Not available
S-EPMC8867181
|
biostudies-literature
Cite
Nitazoxanide controls virus viability through its impact on membrane bioenergetics.
Not available
S-EPMC11681155
|
biostudies-literature
Cite
Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice.
Not available
S-EPMC9069401
|
biostudies-literature
Cite
Synthesis, in vitro bioassays, and computational study of heteroaryl nitazoxanide analogs.
Not available
S-EPMC8177060
|
biostudies-literature
Cite
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial.
Not available
S-EPMC7758778
|
biostudies-literature
Cite
Previous
page
1 / 25
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
25
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
